Abstract
Massive perivillous fibrinoid deposition (MPVFD) and maternal floor infarct (MFI) are part of a spectrum of lesion in which fibrinoid material is laid down between chorionic villi. These lesions can be recurrent and are associated with fetal growth restriction and, when severe, intrauterine fetal demise.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Nelson DM, Crouch EC, Curran EM, Farmer DR. Trophoblast interaction with fibrin matrix: epithelialization of perivillous fibrin deposits as a mechanism for villous repair in the human placenta. Am J Pathol. 1990;136:855–65.
Vernof KK, Benirschke K, Gail M, et al. Maternal floor infarction: relationship to X-cells, major basic protein and adverse perinatal outcome. Am J Obstet Gynecol. 1992;167:1355–63.
Katzman PJ, Genest DR. Maternal floor infarction and massive perivillous fibrin deposition: histological definitions, association with intrauterine fetal growth restriction, and risk or recurrence. Pediatr Dev Pathol. 2002;5:159–64. Erratum 2002;6:102
Naeye RL. Maternal floor infarction. Hum Pathol. 1985;16:823–8.
Andres RL, Kuyper W, Resnik R, et al. The association of maternal floor infarction of the placenta with adverse perinatal outcome. Am J Obstet Gynecol. 1990;163:935–8.
Bane AL, Gillan JE. Massive perivillous fibrinoid causing recurrent placental failure. BJOG. 2003;110:292–5.
Fuke Y, Aono T, Imai S, et al. Clinical significance and treatment of massive intervillous fibrin deposition associated with recurrent fetal growth retardation. Gynecol Obstet Investig. 1994;38:5–9.
Faye-Petersen OM, Ernst LM. Maternal floor infarction and massive perivillous fibrin deposition. Surg Pathol Clin. 2013;6:101–14.
Yu W, Tellier R, Wright JR Jr. Coxsackie virus A16 infection of placenta with massive perivillous fibrin deposition leading to intrauterine fetal demise at 36 weeks gestation. Pediatr Dev Pathol. 2015;18:331–4.
Ordi J, Ismail MR, Ventura PJ, et al. Massive chronic intervillositis of the placenta associated with malaria infection. Am J Surg Pathol. 1998;22:1006–11.
Bendon RW, Hommel AB. Maternal floor infarction in autoimmune disease: two cases. Pediatr Pathol Lab Med. 1996;16:293–7.
Katz VL, Bowes WA Jr, Sierkh AE. Maternal floor infarction of the placenta associated with elevated second trimester maternal serum feto-protein. Am J Perinatol. 1987;4:225–8.
Uxa R, Baczyk D, Kingdom JCP, et al. Genetic polymorphisms in the fibrinolytic system of placentas with massive perivillous fibrin deposition. Placenta. 2010;31:499–505.
Pediatr Pathol Devisme L, Chauvière C, Franquet-Ansart H, et al. Perinatal outcome of placental massive perivillous fibrin deposition: a case-control study. Prenat Diagn. 2017;37:323–8.
Griffin AC, Strauss AW, Bennett MJ, Ernst LM. Mutations in long-chain 3-hydroxyacyl coenzyme a dehydrogenase are associated with placental maternal floor infarction/massive perivillous fibrin deposition. Pediatr Dev Pathol. 2012;15:368–74.
Sebire NJ, Backos M, Goldin RD, Regan L. Placental massive perivillous fibrin deposition associated with antiphospholipid antibody syndrome. Br J Obstet Gynaecol. 2002;109:570–3.
Matern D, Schehata BM, Shekhawa P, et al. Placental floor infarction complicating the pregnancy of a fetus with long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency. Mol Genet Metab. 2001;72:265–8.
Whitten AE, Romero R, Korzeniewski SJ, et al. Evidence of an imbalance of angiogenic/antiangiogenic factors in massive perivillous fibrin deposition (maternal floor infarction): a placental lesion associated with recurrent miscarriage and fetal death. Am J Obstet Gynecol. 2013;208:310.e1–310.e11.
Linn RL, Kiley J, Minturn L, et al. Recurrent massive perivillous fibrin deposition in the placenta associated with fetal renal tubular dysgenesis: case report and literature review. Pediatr Dev Pathol. 2013;16:378–86.
Romero R, Whitten A, Korzeniewski SJ, et al. Maternal floor infarction/massive perivillous fibrin deposition: a manifestation of maternal antifetal rejection. Am J Reprod Immunol. 2013;70:285–98.
Adams-Chapman I, Vaucher YE, Bejar RF, et al. Maternal floor infarction of the placenta: association with central nervous system injury and adverse neurodevelopmental outcome. J Perinatol. 2002;22:236.
Benirschke K, Driscoll SG. The pathology of the human placenta. New York: Springer-Verlag; 1967.
Abdulghani S, Moretti F, Gruslin A, Grynspan D. Recurrent massive perivillous fibrin deposition and chronic intervillositis treated with heparin and intravenous immunoglobulin: a case report. J Obstet Gynaecol Can. 2017;39:676–81.
Chaiworapongsa T, Romero R, Korzeniewski SJ, et al. Pravastatin to prevent recurrent fetal death in massive perivillous fibrin deposition of the placenta (MPFD). J Matern Fetal Neonatal Med. 2016;29:855–62.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Katzman, P.J., Ernst, L.M., Scheimberg, I.B. (2019). Massive Perivillous Fibrinoid Deposition and Maternal Floor Infarct . In: Khong, T., Mooney, E., Nikkels, P., Morgan, T., Gordijn, S. (eds) Pathology of the Placenta. Springer, Cham. https://doi.org/10.1007/978-3-319-97214-5_8
Download citation
DOI: https://doi.org/10.1007/978-3-319-97214-5_8
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-97213-8
Online ISBN: 978-3-319-97214-5
eBook Packages: MedicineMedicine (R0)